Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.
暂无分享,去创建一个
[1] M. Tschöp,et al. Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans. , 2012, The Journal of clinical endocrinology and metabolism.
[2] P. Scherer,et al. Adiponectin: mechanistic insights and clinical implications , 2012, Diabetologia.
[3] J. Repa,et al. Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells. , 2011, Molecular endocrinology.
[4] Martin S. Taylor,et al. Glucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor , 2010, Science.
[5] C. Meyer. Final Answer: Ghrelin Can Suppress Insulin Secretion in Humans, but Is It Clinically Relevant? , 2010, Diabetes.
[6] M. Mulholland,et al. Modulation of Ghrelin O-Acyltransferase Expression in Pancreatic Islets , 2010, Cellular Physiology and Biochemistry.
[7] M. Tschöp,et al. Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans , 2010, Diabetes.
[8] B. Estour,et al. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. , 2010, The Journal of clinical endocrinology and metabolism.
[9] A. Murphy,et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice , 2010, Proceedings of the National Academy of Sciences.
[10] R. Datta,et al. Ghrelin in the regulation of body weight and metabolism , 2010, Frontiers in Neuroendocrinology.
[11] P. Pfluger,et al. GOAT links dietary lipids with the endocrine control of energy balance , 2009, Nature Medicine.
[12] N. Møller,et al. Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling , 2008, Diabetes.
[13] M. Thorner,et al. Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. , 2008, The Journal of clinical endocrinology and metabolism.
[14] D. Witcher,et al. Ghrelin octanoylation mediated by an orphan lipid transferase , 2008, Proceedings of the National Academy of Sciences.
[15] N. Grishin,et al. Identification of the Acyltransferase that Octanoylates Ghrelin, an Appetite-Stimulating Peptide Hormone , 2008, Cell.
[16] N. Møller,et al. Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects. , 2007, American journal of physiology. Endocrinology and metabolism.
[17] M. Nakata,et al. Blockade of Pancreatic Islet–Derived Ghrelin Enhances Insulin Secretion to Prevent High-Fat Diet–Induced Glucose Intolerance , 2006, Diabetes.
[18] K. Lalić,et al. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients. , 2006, The Journal of clinical endocrinology and metabolism.
[19] C. Saper,et al. Expression of ghrelin receptor mRNA in the rat and the mouse brain , 2006, The Journal of comparative neurology.
[20] Sachi Kato,et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas , 2005, Regulatory Peptides.
[21] C. Delporte,et al. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. , 2004, Endocrinology.
[22] M. Tschöp,et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. , 2004, Endocrine reviews.
[23] M. Nakazato,et al. Fasting plasma ghrelin levels in subtypes of anorexia nervosa , 2003, Psychoneuroendocrinology.
[24] G. Pacini,et al. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. , 2003, Endocrinology.
[25] N. Kohno,et al. Increased plasma ghrelin level in lung cancer cachexia. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] F. Sundler,et al. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas , 2002, Regulatory Peptides.
[27] S. Kahn,et al. Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus. , 2001, The Journal of clinical endocrinology and metabolism.
[28] M. Tschöp,et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. , 2001, European journal of endocrinology.
[29] W. Shimizu,et al. Elevated Circulating Level of Ghrelin in Cachexia Associated With Chronic Heart Failure: Relationships Between Ghrelin and Anabolic/Catabolic Factors , 2001, Circulation.
[30] M. Papotti,et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[31] B. Wisse,et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.
[32] M. Tschöp,et al. Ghrelin induces adiposity in rodents , 2000, Nature.
[33] M. Nakazato,et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.
[34] S. Dinneen,et al. Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning , 1998, Diabetologia.
[35] R. Bergman,et al. Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.
[36] R N Bergman,et al. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. , 1987, The Journal of clinical investigation.
[37] F. Momany,et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. , 1984, Endocrinology.
[38] R. DeFronzo,et al. The effect of growth hormone on glucose metabolism and insulin secretion in man. , 1982, The Journal of clinical endocrinology and metabolism.
[39] E. Cerasi,et al. Acute effects of exogenous growth hormone in man: time- and dose-bound modification of glucose tolerance and glucose-induced insulin release. , 1975, Acta endocrinologica.
[40] L. Frohman,et al. Acute effects of human growth hormone on insulin secretion and glucose utilization in normal and growth hormone deficient subjects. , 1967, The Journal of clinical endocrinology and metabolism.
[41] E. B. Page. Ordered Hypotheses for Multiple Treatments: A Significance Test for Linear Ranks , 1963 .
[42] Wenyaw Chan,et al. Statistical Methods in Medical Research , 2013, Model. Assist. Stat. Appl..
[43] K. Kangawa,et al. Therapeutic Potential of Ghrelin in the Treatment of Heart Failure , 2012, Drugs.
[44] J. Holst,et al. The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. , 2008, Diabetes care.
[45] R. Wadwa,et al. β-Cell Function, Insulin Sensitivity, and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults , 2006 .
[46] C Cobelli,et al. Minimal modeling, partition analysis, and the estimation of insulin sensitivity. , 1980, Federation proceedings.